Work

Mast Cell and Eosinophil Counts in Gastric and Duodenal Biopsy Specimens From Patients With and Without Eosinophilic Gastroenteritis

Year: 2020

Type: article

Study design: Observational Study

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2020.08.013

Authors: Craig C. Reed, Robert M. Genta, Bradford A. Youngblood, Joshua B. Wechsler, Evan S. Dellon

Institutions: University of North Carolina at Chapel Hill, Dallas VA Medical Center, The University of Texas Southwestern Medical Center, Allakos (United States), Lurie Children's Hospital

Language: English

Topic: Eosinophilic Esophagitis

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, GlaxoSmithKline Australia, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Environmental Health Sciences

Awards: G2220261543, Budesonide versus fluticasone for treatment of eosinophilic esophagitis, G407118926, G6943022892, G9000019418, G9000033364, Center for Gastrointestinal Biology and Disease, UNC Center for Environmental Health and Susceptibility, Cancer Center Support Grant

OpenAlex ID: W3048831593

FWCI: 8.672

Cites: 44

Cited by: 62

Related to: 10